InvestorsHub Logo

pte

Followers 6
Posts 199
Boards Moderated 0
Alias Born 01/29/2014

pte

Re: A deleted message

Wednesday, 07/26/2017 4:44:01 PM

Wednesday, July 26, 2017 4:44:01 PM

Post# of 399508

FDA Ad Com thumbs down on Intellipharmaceutics' oxycodone
Jul. 26, 2017 4:41 PM ET|By: Douglas W. House, SA News Editor
Intellipharmaceutics (NASDAQ:IPCI) is poised for a significant down move after the FDA's Advisory Committees rejected its marketing application for an abuse-deterrent extended-release formulation of oxycodone.
Vote was 22 - 1 against approval.
Vote was 19 - 4 against properties of Rexista sufficient to deter IV abuse. Unanimous opinion that more data are needed to support claim of IV abuse deterrence
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News